Logo

American Heart Association

  2
  0


Final ID: 4121793

A Pressure-Volume Loops Approach Predicts Outcomes After Double Switch Operation For Congenitally Corrected Transposition Of The Great Arteries with Intact Ventricular Septum

Abstract Body (Do not enter title and authors here): Background: Double switch operation (DSO) for congenitally corrected transposition of the great arteries with intact ventricular septum (ccTGA) has a high rate of post-DSO LV dysfunction.
Hypothesis: LV pressure-volume area (PVA), a surrogate of myocardial O2 consumption, is a superior marker of LV preparedness and is associated with adverse outcomes after DSO.
Aims: 1. Derive a mathematical relationship to estimate LV PVA (ePVA) from catheterization (pressure) and imaging (volumetric) data, using directly measured PVA (mPVA) as reference 2. Assess if lower ratio of LV ePVA to RV ePVA (as an internal control) is associated with adverse outcome after DSO.
Methods: Aim 1: Using conductance catheter derived invasive subpulmonary LV PV loops, mPVA was recorded as the sum of stroke work (SW) and potential energy (PE). A mathematical relationship was established with standard catheterization/imaging data to estimate ePVA. Aim 2: In a retrospective cohort, LV:RV ePVA ratio was calculated as above, and along with standard clinical metrics, assessed for relationship with a composite outcome of ≥ moderate LV dysfunction, transplant, or death post-DSO.
Results: Aim 1: In 20 PV loop studies in 18 pre-DSO patients, there was a strong linear correlation between measured and estimated SW and PE (R2 > 0.9 and p<0.0001 for both). ePVA yielded high agreement and low bias compared to mPVA (mean bias 0.5±11%). Aim 2: Composite outcome occurred in 6/42 DSO patients (14%). LV:RV ePVA ratio (0.57 [0.49, 0.61] vs 0.90 [0.73, 1.1], p<0.001) and LV:RV pressure ratio (0.80 [0.77, 0.87] vs 1.13 [1.01, 1.23], p<0.001) were lower in those with adverse outcome. There were no differences in other pre-operative parameters. On time to event analysis, lower LV:RV ePVA ratio was the strongest determinant (HR 39, 95% CI 15-100; C Index 0.94), while lower LV:RV pressure ratio was the only other predictor (HR 24, 95% CI 13-42; C Index 0.88). In 8 patients with borderline pressure ratios of 0.77-0.88, ePVA ratio was an excellent discriminator - 3 patients with ePVA ratio of ≥0.67 had good outcomes, whereas 5 patients with ePVA ratio <0.67 had adverse outcomes.
Conclusion: LV:RV ePVA ratio >0.67 is a strong and novel predictor of LV preparedness for DSO in patients with ccTGA.
  • Thatte, Nikhil  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Del Nido, Pedro  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Ghelani, Sunil  ( Boston Childrens Hospital , Boston , Massachusetts , United States )
  • Hammer, Peter  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Marx, Gerald  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Beroukhim, Rebecca  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Gauvreau, Kimberlee  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Callahan, Ryan  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Prakash, Ashwin  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Emani, Sitaram  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Hoganson, David  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Nikhil Thatte: DO NOT have relevant financial relationships | Pedro Del Nido: DO NOT have relevant financial relationships | Sunil Ghelani: DO NOT have relevant financial relationships | Peter Hammer: DO NOT have relevant financial relationships | Gerald Marx: DO NOT have relevant financial relationships | Rebecca Beroukhim: DO NOT have relevant financial relationships | Kimberlee Gauvreau: DO NOT have relevant financial relationships | Ryan Callahan: No Answer | Ashwin Prakash: DO NOT have relevant financial relationships | Sitaram Emani: DO have relevant financial relationships ; Ownership Interest:Cellvie:Active (exists now) | David Hoganson: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Congenital Heart Surgery and ACHD

Saturday, 11/16/2024 , 01:30PM - 02:45PM

Abstract Oral Session

More abstracts on this topic:
Assessing Knowledge, Attitudes, and Practices Regarding the American Heart Association’s Framework for Cardiovascular Health in Pediatrics

Ortiz Robin, Chan Debra, Nita Abigail, Heffron Sean, Nagpal Nikita, Duh-leong Carol

A Novel Cardiac Simulator "ped UT-Heart" to Support Decision-Making in Surgical Procedures for Complex Congenital Heart Disease

Shiraishi Isao, Kurosaki Kenichi, Iwai Shigemitsu, Washio Takumi, Sugiura Seiryo, Hisada Toshiaki

More abstracts from these authors:
Annulo-Leaflet Mitral Ring – A Distinct Form of Valvar Endocardial Fibroelastosis

Von Piechowski Magnus, Del Nido Pedro, Friehs Ingeborg, Diaz-gil Daniel, Saraci Kerstin, Rech Lavinia, Lang Nora, Marx Gerald, Carreon Chrystalle, Sanders Stephen, Emani Sitaram

Cellular Crosstalk in Endocardial Fibroelastosis: NRG Signaling Dysregulation Contributes to Fibrosis and Myocardial Dysfunction in Hypoplastic Left Heart Complex

Diaz-gil Daniel, Seidman Christine, Friehs Ingeborg, Morton Sarah, Brown Kemar, Wei Eric, Saraci Kerstin, Von Piechowski Magnus, Emani Sitaram, Del Nido Pedro, Seidman Jonathan

You have to be authorized to contact abstract author. Please, Login
Not Available